Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

43.10
-1.8600-4.14%
Post-market: 43.250.1500+0.35%19:07 EDT
Volume:22.68M
Turnover:988.34M
Market Cap:62.46B
PE:17.46
High:44.42
Open:44.13
Low:42.78
Close:44.96
52wk High:105.72
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:1.14
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.51
PE(LYR):22.22

Loading ...

Boston Scientific Exec Says Updated Forecast Reflects a "Realistic View" of H2 2026

THOMSON REUTERS
·
Jul 29

U.S. Stocks on the MOVE-Seagate, Bloom Energy, Generac

Reuters
·
Jul 29

Boston Scientific Shares up 3.7% Premarket After Q2 Results Beat

THOMSON REUTERS
·
Jul 29

Boston Scientific Rises After Quarterly Results Beat Estimates

Reuters
·
Jul 29

Boston Scientific Logs Higher 2Q, Cuts Outlook Ahead of Restructuring

Dow Jones
·
Jul 29

Boston Scientific Trims Annual Profit Forecast on Softer Watchman Device Demand

Reuters
·
Jul 29

Ceribell Names Thomas West, Sharon O’Keefe to Board of Directors

Reuters
·
Jul 29

Stock Track | Boston Scientific Soars 6.32% in Pre-Market on Q2 Earnings Beat

Stock Track
·
Jul 29

Boston Scientific Q2 Adjusted Earnings, Revenue Rise; Lowers 2026 Guidance

MT Newswires Live
·
Jul 29

Boston Scientific Q2 Results Beat Estimates on Cardiovascular Strength

Reuters
·
Jul 29

GUIDANCE: (BSX) Boston Scientific Expects 2026 Adjusted EPS Range $3.28 to $3.32, vs. FactSet Est of $3.36

MT Newswires Live
·
Jul 29

Boston Scientific Q2 Adj. EPS $0.86 Beats $0.83 Estimate, Sales $5.442B Beat $5.361B Estimate

Benzinga Earnings
·
Jul 29

Boston Scientific Corp Outlook Q3 Adj EPS $0.80 to $0.82

THOMSON REUTERS
·
Jul 29

Boston Scientific Q2 EPS USD 0.61

THOMSON REUTERS
·
Jul 29

Boston Scientific: Estimates Net Sales Growth for Q3 of 2026, to be About 3 to 5 Percent on Reported and Organic Basis

THOMSON REUTERS
·
Jul 29

Boston Scientific Outlook FY Organic Revenue Growth 5-6%

THOMSON REUTERS
·
Jul 29

Boston Scientific Q2 Net Income USD 905 Million

THOMSON REUTERS
·
Jul 29

Boston Scientific Announces Results for Second Quarter 2026

THOMSON REUTERS
·
Jul 29

Movement Alert|Boston Scientific Rises 3.13% in Pre-Market Trading, Q2 Earnings Release Imminent as UBS Highlights Underappreciated Growth Drivers

Market Focus
·
Jul 29

Jefferies Reaffirms Their Buy Rating on Boston Scientific (BSX)

TIPRANKS
·
Jul 29